1. Home
  2. UNH vs MRK Comparison

UNH vs MRK Comparison

Compare UNH & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UnitedHealth Group

UNH

UnitedHealth Group

HOLD

Current Price

$331.86

Market Cap

296.9B

Sector

Health Care

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$106.86

Market Cap

260.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNH
MRK
Founded
1977
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
296.9B
260.2B
IPO Year
1984
N/A

Fundamental Metrics

Financial Performance
Metric
UNH
MRK
Price
$331.86
$106.86
Analyst Decision
Buy
Buy
Analyst Count
25
15
Target Price
$407.88
$111.93
AVG Volume (30 Days)
6.1M
14.5M
Earning Date
01-27-2026
02-03-2026
Dividend Yield
2.66%
3.18%
EPS Growth
24.92
58.08
EPS
19.22
7.56
Revenue
$435,159,000,000.00
$64,235,000,000.00
Revenue This Year
$12.94
$1.98
Revenue Next Year
$1.55
$4.94
P/E Ratio
$17.27
$14.13
Revenue Growth
10.47
1.68
52 Week Low
$234.60
$73.31
52 Week High
$606.36
$107.05

Technical Indicators

Market Signals
Indicator
UNH
MRK
Relative Strength Index (RSI) 50.60 70.67
Support Level $321.65 $96.79
Resistance Level $334.60 $100.94
Average True Range (ATR) 6.90 2.34
MACD -0.08 0.33
Stochastic Oscillator 44.48 96.13

Price Performance

Historical Comparison
UNH
MRK

About UNH UnitedHealth Group

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: